Bonaldi et al. [5] correlated serum levels of e-cadherin and MMP-13 on PCa patients with serum levels of total PSA, free PSA, total testosterone, and clinical evolution, measured before onset of treatment as well as three and six months afterwards. This evidence concerns the gene MMP13 and posterior cortical atrophy.